Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermiaR R Metzger, H M Haughey, D G Wilkins, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Assessment of Inter-Reader Reliability of Fazekas Scoring on Magnetic Resonance Imaging of the Brain in Adult Patients with Sickle Cell DiseaseAoife M Haughey, Roisin M O'Cearbhaill, Stephanie Forté, et al.
Addiction Biology|October 9, 2012
Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug takingBankole A Johnson, John D Roache, Nassima Ait-Daoud, et al.
Anti-Cancer Drugs|April 9, 1999
Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interactionS S Matsumoto, H M Haughey, D M Schmehl, et al.
European Journal of Pharmacology|November 11, 1999
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter functionA E Fleckenstein, H M Haughey, R R Metzger, et al.
Optics Express|March 26, 2014
Nanosecond colloidal quantum dot lasers for sensingB Guilhabert, C Foucher, A-M Haughey, et al.
Archives of General Psychiatry|September 5, 2007
CHRNA4 and tobacco dependence: from gene regulation to treatment outcomeKent E Hutchison, David L Allen, Francesca M Filbey, et al.
World Neurosurgery|December 15, 2021
Predicting Functional Outcome After Decompressive Craniectomy for Malignant Hemispheric Infarction: Clinical and Novel Imaging FactorsAskiel Bruno, Nina Paletta, Uttam Verma, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 4, 2021
Limiting Brain Shift in Malignant Hemispheric Infarction by Decompressive CraniectomyAskiel Bruno, Nina Paletta, Uttam Verma, et al.
Medrxiv : the Preprint Server for Health Sciences|September 11, 2023
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trialJennifer Hendrick, Jennie Z Ma, Heather M Haughey, et al.
Pageof 4